5 SIMPLE STATEMENTS ABOUT HEMGENIX EXPLAINED

Quantity of qualified clients: CDEC reviewed the uncertainty in the volume of people with reasonably serious to significant hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical specialists consulted by CADTH indicated that some individuals who are classified as having mild or average ailment can have a intense bleeding phenotype